MyCardium AI displays picture of health


Innovative MedTech scale-up expands workspace to accommodate growing team.

MyCardium AI specialises in the interpretation and analysis of cardiac imaging using Artificial Intelligence (AI), for both direct care and global pharmaceuticals.

Less than 12 months ago MyCardium AI’s headcount was zero, but within the space of 10 months has rocketed to double figures. Currently employing 11 staff, with another three due to be recruited by the end of the year, MyCardium AI has been busy building its sales and operations teams to attract more customers from the West Coast of America, bringing increased economic impact into Liverpool.

Capitalising on the strong local talent pool, the SME has specifically created ten jobs directly within the north west labour market, as well as recruiting its first Canadian employee. It has also hosted two Internship Students from the University of Liverpool, which is an exercise it hopes to repeat in the future.

The UCL spin-out has now increased its physical presence within the Knowledge Quarter Liverpool (KQ Liverpool) innovation district to accommodate its expanding team, and is doubling its private office space within Liverpool Science Park, as well as maintaining its coworking licence within the Sciontec AI all-inclusive workspace at The Spine.

Antony Shimmin, COO and Co Founder at MyCardium AI, said:

“We value being in an office environment which offers us scalability, the chance to establish a positive corporate culture, and is in close proximity to local universities and national transport networks.

“Whilst being a UCL spin out, the pre-existing collaboration with companies within the Liverpool City Region has led to Liverpool being an ideal place to locate our base operations. The quality of talent here is more competitive, plus it is easier to deal with the funding, business support and professional services landscape.

“KQ Liverpool is a really great thing, and having a big support network readily available on our doorstep is a real bonus for us”.

MyCardium AI has already immersed itself into the Liverpool City Region business ecosystem, with Antony speaking on an expert panel at the LCR Tech Climbers 2023 Launch event, as well as the company being recognised for its innovative technologies in the Tech Climbers list itself. MyCardium AI was also recently named as a Finalist in the NW StartUp Awards 2023, within the highly contested Medtech & Healthtech category.

Looking ahead, a key objective for MyCardium AI over the next 6-12 months is to grow their AI capability directly out of Liverpool, a field of expertise within the company which has been historically centred in London. Growing its localised cardiac imaging capabilities will enhance the overall possibilities within CT, MRI, and Echo diagnostics, broadening imaging technologies through AI.

Ed Critchley, Chief Commercial Officer at MyCardium AI, added:

“We are keen to capitalise on the digital expertise and recognised world-leading strengths within AI solutions  in the Liverpool City Region.

The Sciontec team has been very helpful over the past year in facilitating our ambitions. We have felt supported at every step of the way and look forward to continuing our growth journey within their innovation spaces.”